CN219001692U - Balloon device containing estrogen for preventing uterine cavity adhesion - Google Patents

Balloon device containing estrogen for preventing uterine cavity adhesion Download PDF

Info

Publication number
CN219001692U
CN219001692U CN202222101513.4U CN202222101513U CN219001692U CN 219001692 U CN219001692 U CN 219001692U CN 202222101513 U CN202222101513 U CN 202222101513U CN 219001692 U CN219001692 U CN 219001692U
Authority
CN
China
Prior art keywords
balloon
vertical rod
estrogen
wall
cross rod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202222101513.4U
Other languages
Chinese (zh)
Inventor
何文凤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Luohu Maternal And Child Health Care Hospital
Original Assignee
Shenzhen Luohu Maternal And Child Health Care Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Luohu Maternal And Child Health Care Hospital filed Critical Shenzhen Luohu Maternal And Child Health Care Hospital
Priority to CN202222101513.4U priority Critical patent/CN219001692U/en
Application granted granted Critical
Publication of CN219001692U publication Critical patent/CN219001692U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Surgical Instruments (AREA)

Abstract

The utility model discloses an estrogen-containing balloon device for preventing uterine cavity adhesion; comprises an elastic opening member, a first balloon and a second balloon; the elastic supporting member is formed into a T-shaped structure and comprises a vertical rod, a left elastic cross rod connected to the upper part of the vertical rod leftwards and a right elastic cross rod connected to the upper part of the vertical rod rightwards; the outer wall of the vertical rod is internally provided with a plurality of medicine placing grooves, and each medicine placing groove is filled with estrogen ointment; the first saccule is fixedly arranged at the left side of the vertical rod and the lower part of the left elastic cross rod; the second saccule is fixedly arranged on the right side of the vertical rod and the lower part of the right elastic cross rod; when the left part of the left elastic cross rod and the right part of the right elastic cross rod are downwards bent to be close to or close to the vertical rod, the first balloon and the second balloon are folded. The effect is as follows: after this application is filled in female patient's palace chamber, fixed effect is splendid, can be better and more stable separate female patient's palace chamber inner wall and prevent female patient's palace chamber inner wall adhesion once more to, the estrogen ointment that fills slowly releases, does benefit to female patient's palace chamber endometrium's restoration.

Description

Balloon device containing estrogen for preventing uterine cavity adhesion
Technical Field
The utility model relates to the technical field of medical nursing products, in particular to an estrogen-containing balloon device for preventing uterine cavity adhesion.
Background
Any factors causing endometrial damage can cause intrauterine adhesion, the intrauterine adhesion accounts for about 9l percent relative to pregnancy, is usually generated after an artificial abortion operation or a spontaneous abortion uterine curettage operation and after a postpartum hemorrhage uterine curettage operation, the uterine wall is softer, the depth is not easy to control during uterine curettage, or the uterine cavity is excessively scratched, the negative pressure is excessively high during uterine suction, the time is excessively long; non-pregnancy induced intrauterine adhesions are about 9%, such as endometrial tuberculosis, hysteromyoma resections, diagnostic curettage, and the like.
Therefore, in each large hospital, in order to prevent intrauterine adhesion, it is common for female patients to place a suitable balloon in the uterus of the female patient after surgery to isolate the inner wall of the uterine cavity of the female patient to prevent the possibility of re-adhesion.
For the commonly used balloon component for preventing uterine cavity adhesion, the balloon component mainly comprises a balloon body suitable for being plugged into the uterine cavity of a female patient and a connecting pipe connected with the corresponding balloon body and suitable for being led out from the vagina of the female patient, wherein the corresponding connecting pipe is used for injecting liquid into or inflating the corresponding balloon body so as to enable the corresponding balloon body to bulge in the uterine cavity of the female patient, and therefore separation of the inner wall of the uterine cavity of the female patient is realized to prevent re-adhesion.
The balloon member for preventing uterine cavity adhesion with the structure has certain defects and shortcomings although being widely used.
Specifically, on the one hand, the fixation is not very good, when the female patient moves the body, the female patient is easy to locally shift, so that the possibility that a certain part of the inner wall of the uterine cavity of the female patient still exists when the inner wall of the uterine cavity is not isolated, on the other hand, the female patient has the function of separating the inner wall of the uterine cavity of the female patient to prevent the re-adhesion of the uterine cavity of the female patient, and does not have other functions, such as the function of promoting the repair of the endometrium of the uterine cavity of the female patient, the function of facilitating the external drainage of uterine cavity liquid and the like, so that the female patient has weak practicability.
In this regard, the present inventors have devised the present application based on long-term working experience accumulation to solve the related art problems.
Disclosure of Invention
The present utility model aims to solve at least one of the technical problems in the related art to some extent. Therefore, the utility model aims to provide an estrogen-containing intrauterine adhesion prevention balloon device.
In order to achieve the above object, according to an embodiment of the present utility model, an estrogen-containing intrauterine adhesion prevention balloon device includes an elastic opening member, a first balloon and a second balloon;
the elastic opening member is formed into a T-shaped structure and comprises a vertical rod, a left elastic cross rod connected to the upper part of the vertical rod leftwards and a right elastic cross rod connected to the upper part of the vertical rod rightwards; the outer wall of the vertical rod is internally provided with a plurality of medicine placing grooves, and each medicine placing groove is filled with estrogen ointment; the first saccule is fixedly arranged at the left side of the vertical rod and at the lower part of the left elastic cross rod; the second saccule is fixedly arranged on the right side of the vertical rod and the lower part of the right elastic cross rod;
when the left part of the left elastic cross rod and the right part of the right elastic cross rod are downwards bent to be close to or close to the vertical rod, the first balloon and the second balloon are folded.
In addition, the estrogen-containing intrauterine adhesion prevention balloon device according to the above embodiment of the present utility model may further have the following additional technical features:
according to one embodiment of the utility model, the outer wall of the vertical rod is provided with a plurality of medicine placing grooves uniformly and inwards along the vertical direction.
According to one embodiment of the utility model, the left end of the left elastic cross rod protrudes outwards to form a left smooth ball head; the right end of the right elastic cross rod protrudes outwards to form a right smooth ball head.
According to one embodiment of the utility model, the first balloon and the second balloon are symmetrically arranged about the vertical rod; the elastic opening member, the first balloon and the second balloon form a whole with a semicircular longitudinal section.
According to one embodiment of the utility model, the right surface of the first balloon is adhered with the left side wall of the vertical rod to form a whole, and the upper surface of the first balloon is adhered with the lower wall of the left elastic cross rod to form a whole; the left surface of the second balloon is adhered to the right side wall of the vertical rod to form a whole, and the upper surface of the second balloon is adhered to the lower wall of the right elastic cross rod to form a whole.
According to one embodiment of the present utility model, the device further comprises a soft rubber tube for inflating or injecting liquid into the first balloon and the second balloon;
the lower end of the vertical rod is of a hollow structure so as to form a plug-in cavity penetrating to the bottom of the vertical rod; the left upper part of the inner wall of the insertion cavity is provided with a first via hole communicated with the first balloon; the right upper part of the inner wall of the inserting cavity is provided with a second via hole communicated with the second balloon; the upper end of the thin and soft rubber tube is inserted into the lower part of the insertion cavity in a sealing way so as to be communicated with the first balloon and the second balloon.
According to one embodiment of the utility model, the lower end of the thin and soft rubber tube is provided with a horn-shaped plug downwards, and a sealing plug is arranged on the cover which can be opened and closed outside the horn-shaped plug.
According to one embodiment of the utility model, the uterine cavity liquid drainage tube is made of soft rubber material and used for draining uterine cavity liquid to vagina;
the uterine cavity liquid drainage tube is detachably sleeved outside the thin soft rubber tube, a liquid flowing channel is formed between the inner wall of the uterine cavity liquid drainage tube and the outer wall of the thin soft rubber tube, the upper end of the uterine cavity liquid drainage tube is detachably connected with the lower end of the vertical rod, and a plurality of liquid draining holes communicated with the liquid flowing channel are formed in the outer wall of the upper end of the uterine cavity liquid drainage tube.
According to one embodiment of the utility model, the length of the uterine cavity liquid drainage tube is smaller than that of the soft rubber tube, and the length of the uterine cavity liquid drainage tube is 3.0cm-6.0cm.
According to one embodiment of the utility model, the estrogen ointment is estradiol, diethylstilbestrol, ethinyl estradiol, benzodiol or estriol.
Additional aspects and advantages of the utility model will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the utility model.
Drawings
In order to more clearly illustrate the embodiments of the present utility model or the technical solutions in the prior art, the drawings that are required in the embodiments or the description of the prior art will be briefly described, and it is obvious that the drawings in the following description are only some embodiments of the present utility model, and other drawings may be obtained according to the structures shown in these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a schematic diagram of the overall structure of an estrogen-containing intrauterine adhesion prevention balloon device of the present utility model;
FIG. 2 is an enlarged cross-sectional view of E in FIG. 1;
fig. 3 is an exploded view of an estrogen-containing intrauterine adhesion prevention balloon device of the present utility model;
fig. 4 is an enlarged view of F in fig. 3;
FIG. 5 is an enlarged partial cross-sectional view of the lower end of the vertical rod of FIG. 3 connected to the upper end of the hose;
reference numerals:
an estrogen-containing intrauterine adhesion prevention balloon device 1000;
an elastic opening member 10;
a vertical rod 101;
a medicine placement tank 1011;
estrogen ointment 1012;
a plug cavity 1013;
a first via 1014;
a second via 1015;
an external thread 1016;
a left elastic rail 102;
left round ball 1021;
a right elastic cross bar 103;
right round ball 1031;
a first balloon 20;
a second balloon 30;
a thin soft rubber tube 40;
a horn plug 401;
a sealing plug 402;
a uterine cavity fluid drainage tube 50;
a drain hole 501;
an internal thread 502;
a flow passage 60;
the achievement of the objects, functional features and advantages of the present utility model will be further described with reference to the accompanying drawings, in conjunction with the embodiments.
Detailed Description
Embodiments of the present utility model are described in detail below, examples of which are illustrated in the accompanying drawings, wherein the same or similar reference numerals refer to the same or similar elements or elements having the same or similar functions throughout. The embodiments described below are exemplary and intended to illustrate the present utility model and should not be construed as limiting the utility model, and all other embodiments, based on the embodiments of the present utility model, which may be obtained by persons of ordinary skill in the art without inventive effort, are within the scope of the present utility model.
In the description of the present utility model, it should be understood that the terms "center", "longitudinal", "lateral", "length", "width", "thickness", "upper", "lower", "front", "rear", "left", "right", "vertical", "horizontal", "top", "bottom", "inner", "outer", "clockwise", "counterclockwise", "axial", "circumferential", "radial", etc. indicate orientations or positional relationships based on the orientations or positional relationships shown in the drawings of the specification are merely for convenience in describing the present utility model and simplifying the description, and do not indicate or imply that the device or element being referred to must have a specific orientation, be configured and operated in a specific orientation, and therefore should not be construed as limiting the present utility model.
Furthermore, the terms "first," "second," and the like, are used for descriptive purposes only and are not to be construed as indicating or implying a relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defining "a first" or "a second" may explicitly or implicitly include one or more such feature. In the description of the present utility model, the meaning of "a plurality" is two or more, unless explicitly defined otherwise.
In the present utility model, unless explicitly specified and limited otherwise, the terms "mounted," "connected," "secured," and the like are to be construed broadly and may be, for example, fixedly connected, detachably connected, or integrally connected; can be mechanically or electrically connected; can be directly connected or indirectly connected through an intermediate medium, and can be communication between two elements. The specific meaning of the above terms in the present utility model can be understood by those of ordinary skill in the art according to the specific circumstances.
In the present utility model, unless expressly stated or limited otherwise, a first feature "above" or "below" a second feature may include both the first and second features being in direct contact, as well as the first and second features not being in direct contact but being in contact with each other through additional features therebetween. Moreover, a first feature being "above," "over" and "on" a second feature includes the first feature being directly above and obliquely above the second feature, or simply indicating that the first feature is higher in level than the second feature. The first feature being "under", "below" and "beneath" the second feature includes the first feature being directly under and obliquely below the second feature, or simply means that the first feature is less level than the second feature.
An estrogen-containing anti-uterine adhesion balloon device 1000 according to an embodiment of the present utility model is described in detail below with reference to the accompanying drawings.
Referring to fig. 1 to 5, an estrogen-containing anti-uterine adhesion balloon apparatus 1000 according to an embodiment of the present utility model includes an elastic spreader member 10, a first balloon 20, and a second balloon 30;
the elastic opening member 10 is formed into a T-shaped structure, and comprises a vertical rod 101, a left elastic cross rod 102 connected to the left of the upper part of the vertical rod 101, and a right elastic cross rod 103 connected to the right of the upper part of the vertical rod 101; a plurality of medicine placing grooves 1011 are formed in the outer wall of the vertical rod 101 inwards, and each medicine placing groove 1011 is filled with estrogen ointment 1012; the first balloon 20 is fixedly arranged at the left side of the vertical rod 101 and at the lower part of the left elastic cross rod 102; the second balloon 30 is fixedly arranged on the right side of the vertical rod 101 and at the lower part of the right elastic cross rod 103;
when the left portion of the left elastic cross bar 102 and the right portion of the right elastic cross bar 103 are bent downward to be close to or next to the vertical bar 101, the first balloon 20 and the second balloon 30 are folded.
Based on the foregoing, it is clear that the present application, when embodied, is primarily intended for use as an estrogen-containing anti-uterine adhesion balloon device 1000.
Specifically, when the application is applied, the estrogen ointment 1012 is filled in the medicine placing slots 1011 in advance, the left part of the left elastic cross rod 102 and the right part of the right elastic cross rod 103 are bent downwards to be close to or next to the vertical rod 101 through the operation tool, at this time, the first balloon 20 and the second balloon 30 can be folded so as to facilitate reducing the peripheral volume of the application to send the application from the vagina of a female patient to the uterine cavity of the female patient, the operation tool is removed after the application is sent to the uterine cavity of the female patient, and the left part of the left elastic cross rod 102 and the right elastic cross rod 103 can be elastically reset to retract the first balloon 20 and the second balloon 30, so that the first balloon 20 and the second balloon 30 are separated from the inner wall of the uterine cavity of the female patient to prevent adhesion again.
In the above process of using the present application, the following two points can be summarized:
the first point, the elastic opening member 10 is integrally formed into a T-shaped structure, and includes a vertical rod 101, a left elastic cross rod 102 connected to the left on the upper portion of the vertical rod 101, and a right elastic cross rod 103 connected to the right on the upper portion of the vertical rod 101, so that the elastic opening member is basically the same as a commonly used contraceptive mann-yue ring structure, and is fastened into the uterine cavity of a female patient in a manner of adapting to the uterine cavity of the female patient, and the first balloon 20 and the second balloon 30 are not easy to shift, so that the application has an excellent fixing effect, and is good in use stability, and the inner wall of the uterine cavity of the female patient can be better and more stably separated to prevent the inner wall of the uterine cavity of the female patient from adhesion again.
Second point, because this application the vertical pole 101 outer wall inwards opens has a plurality of medicine grooves 1011 of putting, every put and all fill in the medicine groove 1011 estrogen ointment 1012, the estrogen ointment 1012 of packing can slowly release for be favorable to the restoration of female patient's uterine cavity endometrium, so that this application function is more comprehensive, and the result of use is better.
Furthermore, through the above-mentioned optimal design, even make this application whole practicality strong, be suitable for popularization and application.
Further, in the embodiment, as shown in fig. 3 and fig. 4, according to an embodiment of the present utility model, a plurality of medicine placement slots 1011 are uniformly formed on the outer wall of the vertical rod 101 along the vertical direction.
In this way, the outer wall surface of the vertical rod 101 of the present application contains the estrogen ointment 1012 in every direction, so that the estrogen ointment can be released to be evenly dissociated at every corner in the uterine cavity of the female patient, and the repair of the endometrium of the uterine cavity of the female patient can be better facilitated.
Still further, in the embodiment, as shown in fig. 1 and 3, according to an embodiment of the present utility model, a left round ball 1021 is formed by protruding the left end of the left elastic cross bar 102; the right end of the right elastic cross bar 103 protrudes outwards to form a right round ball 1031.
Therefore, it is clear that, for the female patient, the uterine cavity shape gas is formed into an inverted triangle, the left round ball 1021 can be clamped and fixed to one oviduct opening of the female patient Gong Qiangdi, the right round ball 1031 can be clamped and fixed to two oviduct openings of the female patient Gong Qiangdi, and the lower end of the vertical rod 101 can be limited at the position of the cervical inner opening of the uterine cavity of the female patient, so that the uterine cavity is not easy to shift and free everywhere in actual use.
Moreover, the left round ball 1021 and the right round ball 1031 are good in smoothness, so that female patients Gong Qiangdi, gong Qiangdi and the like are not prone to being injured by propping up, and the application is good in use comfort for female patients.
Further, in the embodiment, as shown in fig. 1 and 3, according to an embodiment of the present utility model, the first balloon 20 and the second balloon 30 are symmetrically disposed about the vertical rod 101; the elastic spreader member 10, the first balloon 20, and the second balloon 30 are formed to have a semicircular longitudinal section.
So, then make this application when in actual use, can just be fixed in female patient's palace intracavity, elasticity struts component 10, first sacculus 20 and the whole that second sacculus 30 constitutes can be great in area separate female patient's palace intracavity wall and prevent female patient's palace intracavity wall adhesion again.
Furthermore, in the implementation, according to an embodiment of the present utility model, the right surface of the first balloon 20 is adhered to the left side wall of the vertical rod 101 to form a whole, and the upper surface of the first balloon 20 is adhered to the lower wall of the left elastic cross rod 102 to form a whole; the left surface of the second balloon 30 is adhered to the right side wall of the vertical rod 101 to form a whole, and the upper surface of the second balloon 30 is adhered to the lower wall of the right elastic cross rod 103 to form a whole.
Thus, the first balloon 20 and the second balloon 30 are connected with good stability and are not easy to fall off.
On this basis, according to one embodiment of the present utility model, as shown in fig. 3, 4 and 5, the present application further includes a thin and flexible hose 40 for inflating or injecting the first balloon 20 and the second balloon 30;
wherein the lower end of the vertical rod 101 is hollow to form a plugging cavity 1013 penetrating to the bottom thereof; the upper left part of the inner wall of the plugging cavity 1013 is provided with a first via hole 1014 communicated with the first balloon 20; the right upper part of the inner wall of the plugging cavity 1013 is provided with a second through hole 1015 communicated with the second balloon 30; the upper end of the thin and flexible tube 40 is inserted into the lower portion of the insertion cavity 1013 so as to be communicated with the first balloon 20 and the second balloon 30.
It should be noted that, the first balloon 20 and the second balloon 30 may be used directly when they are not inflated or injected, but the application further includes a soft rubber tube 40 for inflating or injecting the fluid into the first balloon 20 and the second balloon 30, after the application is built into the uterine cavity of the female patient, the lower end of the soft rubber tube 40 may be exposed out of the vagina of the female patient, so that the lower end of the soft rubber tube 40 is connected to an inflation device or an injection device, so that the first balloon 20 and the second balloon 30 may be inflated or injected to a certain volume, so that the application can expand the contact surface with the uterine cavity inner wall of the female patient, and the separation of the uterine cavity inner wall of the female patient to prevent the re-adhesion of the uterine cavity inner wall of the female patient is better facilitated.
Furthermore, through the above-mentioned optimal design, even make this application whole result of use can obtain effectively improving.
In addition, in the embodiment, according to an embodiment of the present utility model, a horn-shaped plug 401 is disposed at the lower end of the soft rubber tube 40, and a sealing plug 402 is disposed on the openable cover outside the horn-shaped plug 401.
Therefore, the sealing plug 402 is pulled out from the horn-shaped plug 401 in advance, and is inflated or injected into the first balloon 20 and the second balloon 30, so that after the sealing plug 402 is inflated to a certain volume, the sealing plug 402 can be plugged into the horn-shaped plug 401 again, the lower end of the soft rubber tube 40 is sealed, and after the first balloon 20 and the second balloon 30 are inflated to a certain volume, the sealing plug can be well maintained in the corresponding volume, so that the application is stable.
It should be noted that, in the present technical solution, referring to fig. 1 and 3, according to an embodiment of the present utility model, the present application further includes a uterine cavity liquid drainage tube 50 made of a soft rubber material for draining uterine cavity liquid to vagina;
wherein, the uterine cavity liquid drainage tube 50 is detachably sleeved outside the soft rubber tube 40, a liquid flowing channel 60 is formed between the inner wall of the uterine cavity liquid drainage tube and the outer wall of the soft rubber tube 40, the upper end of the uterine cavity liquid drainage tube is detachably connected with the lower end of the vertical rod 101, and a plurality of liquid draining holes 501 communicated with the liquid flowing channel 60 are formed on the outer wall of the upper end of the uterine cavity liquid drainage tube.
Therefore, after the vaginal fluid is placed in the vaginal fluid drainage device, the vaginal fluid generated in the uterine cavity of the female patient can enter the fluid passage 60 through the plurality of fluid drainage holes 501 and then flow to the vagina of the female patient, so that the vaginal fluid can be easily drained.
Thereby, the estrogen-containing uterine cavity adhesion prevention balloon device 1000 provided by the application has the function of facilitating external drainage of uterine cavity liquid of female patients, so that the practicability is stronger.
It should be further added that, in the specific implementation, according to an embodiment of the present utility model, the length of the uterine cavity fluid drainage tube 50 is smaller than the length of the soft rubber tube 40, and the length of the uterine cavity fluid drainage tube 50 is 3.0cm-6.0cm.
It should be noted here that, in practice, the female vagina depth will generally be 7.0cm-12.0cm, so that, in this application, the length of the uterine cavity fluid drainage tube 50 is set to 3.0cm-6.0cm, so that it will be substantially completely within the vagina of the female patient without being exposed.
Preferably, in the present embodiment, the length of the uterine cavity fluid drainage tube 50 is set to be 4.5cm.
It is further appreciated that in particular embodiments, the estrogen ointment 1012 is estradiol, diethylstilbestrol, ethinyl estradiol, benzodiol or estriol according to one embodiment of the utility model.
It should be further added that, in the embodiment, when the upper end of the soft rubber tube 40 is inserted into the lower portion of the insertion cavity 1013 in a sealing manner, it is preferably connected into a whole by an adhesive, so that the upper end of the soft rubber tube does not cover the first via 1014 and the second via 1015, thereby realizing that the soft rubber tube can be communicated with the first balloon 20 and the second balloon 30.
Moreover, in the preferred scheme, the vertical pole 101 lower extreme is equipped with external screw thread 1016, palace chamber liquid drainage tube 50 upper end is equipped with threaded connection external screw thread 1016's internal screw thread 502, so, even make palace chamber liquid drainage tube 50 not only firm in connection, still can dismantle it when need not use it for this application uses in a flexible way.
In particular, the length of the hose 40 is set to be about 16.0cm so as not to be long or short.
To sum up, this application provides another including estrogen prevents palace chamber adhesion sacculus device 1000, when the implementation, after the stopper is to female patient's palace chamber, fixed effect is splendid, and the use steadiness is good, can be better and more stable separate female patient's palace chamber inner wall and prevent female patient's palace chamber inner wall adhesion once more, and, every that vertical pole 101 outer wall was equipped with put the medicine inslot 1011 is all filled with estrogen ointment 1012, and the packing estrogen ointment 1012 can slowly release for be favorable to female patient's palace chamber inner membranous restoration, so that this application function is more comprehensive, and excellent in use effect, simultaneously, this application still has the function that does benefit to female patient's palace chamber liquid to external drainage concurrently, makes the practicality stronger.
Furthermore, as a whole, the multifunctional integrated paper box has an excellent actual use effect, and has a good market popularization value, so that the multifunctional integrated paper box is very popular and can be effectively popularized.
Other embodiments, etc., are not illustrated herein.
Also, in the description of the present specification, the descriptions of the terms "one embodiment," "some embodiments," "examples," "specific examples," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present utility model. In this specification, schematic representations of the above terms are not necessarily directed to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Furthermore, the different embodiments or examples described in this specification and the features of the different embodiments or examples may be combined and combined by those skilled in the art without contradiction.
The foregoing description is only of the preferred embodiments of the present utility model and is not intended to limit the scope of the utility model, and all equivalent structural changes made by the description of the present utility model and the accompanying drawings or direct/indirect application in other related technical fields are included in the scope of the utility model.

Claims (10)

1. An estrogen-containing intrauterine adhesion prevention balloon device is characterized by comprising an elastic opening member, a first balloon and a second balloon;
the elastic supporting member is formed into a T-shaped structure and comprises a vertical rod, a left elastic cross rod connected to the upper part of the vertical rod leftwards and a right elastic cross rod connected to the upper part of the vertical rod rightwards; the outer wall of the vertical rod is internally provided with a plurality of medicine placing grooves, and each medicine placing groove is filled with estrogen ointment; the first saccule is fixedly arranged at the left side of the vertical rod and the lower part of the left elastic cross rod; the second saccule is fixedly arranged on the right side of the vertical rod and the lower part of the right elastic cross rod;
when the left part of the left elastic cross rod and the right part of the right elastic cross rod are downwards bent to be close to or close to the vertical rod, the first balloon and the second balloon are folded.
2. The estrogen-containing intrauterine adhesion prevention balloon device according to claim 1, wherein a plurality of medicine placement grooves are uniformly opened on the outer wall of the vertical rod along the vertical inward direction.
3. The estrogen-containing intrauterine adhesion prevention balloon device according to claim 1, wherein the left end of the left elastic cross bar is outwardly protruded to form a left round ball; the right end of the right elastic cross rod protrudes outwards to form a right smooth ball head.
4. The estrogen-containing anti-uterine adhesion balloon device according to claim 1, wherein the first balloon and the second balloon are symmetrically disposed about a vertical rod; the elastic opening member, the first balloon and the second balloon form a semicircular longitudinal section.
5. The estrogen-containing intrauterine adhesion prevention balloon device according to claim 1, wherein the right surface of the first balloon is integrally adhered to the left side wall of the vertical rod, and the upper surface of the first balloon is integrally adhered to the lower wall of the left elastic cross rod; the left surface of the second saccule is adhered with the right side wall of the vertical rod to form a whole, and the upper surface of the second saccule is adhered with the lower wall of the right elastic cross rod to form a whole.
6. The estrogen-containing anti-uterine adhesion balloon device according to claim 5, further comprising a flexible hose for inflating or infusing the first balloon and the second balloon;
the lower end of the vertical rod is of a hollow structure so as to form a plug-in cavity penetrating to the bottom of the vertical rod; the left upper part of the inner wall of the insertion cavity is provided with a first via hole communicated with the first balloon; the right upper part of the inner wall of the inserting cavity is provided with a second via hole communicated with a second balloon; the upper end of the thin soft rubber tube is inserted into the lower part of the insertion cavity in a sealing way so as to be communicated with the first balloon and the second balloon.
7. The estrogen-containing cervical adhesion prevention balloon apparatus according to claim 6, wherein the lower end of the soft rubber tube is provided with a horn-shaped plug downwards, and the openable cover outside the horn-shaped plug is provided with a sealing plug.
8. The estrogen-containing intrauterine adhesion prevention balloon device according to claim 6, further comprising a intrauterine fluid drainage tube made of a soft gel material for draining intrauterine fluid to the vagina;
the detachable uterine cavity liquid drainage tube is sleeved outside the thin soft rubber tube, a liquid flowing channel is formed between the inner wall of the uterine cavity liquid drainage tube and the outer wall of the thin soft rubber tube, the upper end of the uterine cavity liquid drainage tube is detachably connected with the lower end of the vertical rod, and a plurality of liquid draining holes communicated with the liquid flowing channel are formed in the outer wall of the upper end of the uterine cavity liquid drainage tube.
9. The estrogen-containing intrauterine adhesion prevention balloon device according to claim 8, wherein the length of the intrauterine fluid drainage tube is smaller than the length of the thin and flexible tube, and the length of the intrauterine fluid drainage tube is 3.0cm-6.0cm.
10. The estrogen-containing anti-uterine adhesion balloon device according to any one of claims 1-9, wherein the estrogen cream is estradiol, diethylstilbestrol, ethinyl estradiol, benzofurandiol or estriol.
CN202222101513.4U 2022-08-10 2022-08-10 Balloon device containing estrogen for preventing uterine cavity adhesion Active CN219001692U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202222101513.4U CN219001692U (en) 2022-08-10 2022-08-10 Balloon device containing estrogen for preventing uterine cavity adhesion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202222101513.4U CN219001692U (en) 2022-08-10 2022-08-10 Balloon device containing estrogen for preventing uterine cavity adhesion

Publications (1)

Publication Number Publication Date
CN219001692U true CN219001692U (en) 2023-05-12

Family

ID=86251018

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202222101513.4U Active CN219001692U (en) 2022-08-10 2022-08-10 Balloon device containing estrogen for preventing uterine cavity adhesion

Country Status (1)

Country Link
CN (1) CN219001692U (en)

Similar Documents

Publication Publication Date Title
EP0141589A1 (en) Inflatable uterine hemostat
CN210078014U (en) Intrauterine adhesion prevention device after uterine cavity operation
CN219001692U (en) Balloon device containing estrogen for preventing uterine cavity adhesion
CN111166416A (en) Lower uterine segment hemostasis structure for caesarean section
US20090099515A1 (en) Trans-cervical catheter having a conical-shaped balloon
CN218738894U (en) Leak protection formula hysteroscope
CN215194881U (en) Joint of liquid instillation device for oviduct
CN215275348U (en) Anti-adhesion supporting device for uterine cavity
CN211884726U (en) Flushable pigtail bladder fistulization tube
CN211094413U (en) Multifunctional triangular sacculus support easy to operate
CN208943187U (en) A kind of Medical urethral catheter
CN209661755U (en) A kind of cervical dilator bar with water pocket
KR20010002164A (en) A device to contract the uterus
CN218739302U (en) Improved ring feeder
CN217907883U (en) Intrauterine hemostat for obstetrics and gynecology department
CN219183930U (en) Intrauterine hemostasis equipment suitable for gynaecology and obstetrics
CN219230069U (en) Water sac labor induction device
CN217310440U (en) Disposable vagina plugging device for laparoscopic hysterectomy
KR102619357B1 (en) Intrauterine balloon tamponade catheter for abdominal insertion and medical device comprising the same
CN211560229U (en) Lower uterine segment hemostasis structure for caesarean section
CN220757744U (en) Uterine cavity suction and compression device
CN213851273U (en) Novel uterine cavity support
CN216854938U (en) Thin endometrium molding device for rat
CN211357372U (en) Disposable cervical dilation mold
CN219375845U (en) Intestinal stomal prolapse treatment device

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant